Skip to content
Search

Latest Stories

Diabetes drug prescriptions rises eight million since 2015, NHS report says

Nearly 60 million drugs were used to treat people with diabetes in England last year, increasing eight million since 2015-16, a report by the NHS revealed.

The latest data released by the NHS Business Service Authority (NHSBSA) showed that 57.9 million drugs were prescribed during 2020-21, costing the exchequer £1.19 billion. It accounted for 12.5 per cent of the total spend on all prescription items.


The data showed a steep increase from 2015-16, where 49.7 million diabetes items were prescribed for a cost of £958 million, accounting for 10.4 per cent of the total spend.

The study entitled ‘Prescribing for diabetes England 2015-2016 to 2020-2021’, also found that there were over 3.05 million identified patients, who were prescribed diabetes drugs, against 3 million patients in 2019-20, and 2.70 million in 2015-16.

It further revealed that most people who were prescribed drugs for diabetes last year lived in deprived areas.

The most common age group among the patients in 2020-21 was 70 to 74, higher than 65 to 69 registered in 2015-16.

Besides, cost of antidiabetic drugs increased by 62 per cent from £423m in 2015-16 to £686m last year.

In 2020-21, 43.1 million antidiabetic drug items were prescribed.

The most deprived areas in England have the highest number of identified patients being prescribed drugs used in treating diabetes in 2020-21.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less